Palbociclib and Glycosylated haemoglobin increased - a phase IV clinical study of FDA data

Summary:

Glycosylated haemoglobin increased is reported as a side effect among people who take Palbociclib (palbociclib), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Letrozole, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Glycosylated haemoglobin increased when taking Palbociclib. It is created by eHealthMe based on reports of 11,617 people who have side effects when taking Palbociclib from the FDA, and is updated regularly.

What is Palbociclib?

Palbociclib has active ingredients of palbociclib. eHealthMe is studying from 11,622 Palbociclib users. Check the latest studies of Palbociclib.

What is Glycosylated haemoglobin increased?

Glycosylated haemoglobin increased is found to be associated with 936 drugs and 950 conditions by eHealthMe. Check the latest studies of Glycosylated haemoglobin increased.

On Jul, 08, 2026

11,617 people reported to have side effects when taking Palbociclib.
Among them, 58 people (0.5%) have Glycosylated haemoglobin increased.

Could Palbociclib cause Glycosylated haemoglobin increased?

Among these 58 people:

How long have people been on Palbociclib when they have Glycosylated haemoglobin increased? *

What is the gender of people who have Glycosylated haemoglobin increased when taking Palbociclib? *

female: 100 %
male: 0.0 %

What is the age of people who have Glycosylated haemoglobin increased when taking Palbociclib? *

What are other drugs people take besides Palbociclib? *

What are other side effects people have besides Glycosylated haemoglobin increased? *

Haemoglobin Decreased: 43 people, 74.14%
White Blood Cell Count Decreased: 39 people, 67.24%
Neoplasm Progression (growth of tumour): 31 people, 53.45%
Thrombocytopenia (decrease of platelets in blood): 23 people, 39.66%
Pain: 17 people, 29.31%
Blood Glucose Increased: 15 people, 25.86%
Blood Urea Increased: 14 people, 24.14%
Full Blood Count Abnormal: 14 people, 24.14%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 13 people, 22.41%
Pain In Extremity: 13 people, 22.41%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 42 people, 72.41%
Pain: 3 people, 5.17%
Breast Cancer: 3 people, 5.17%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Palbociclib and have Glycosylated haemoglobin increased?

- Check whether Glycosylated haemoglobin increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Palbociclib:

Palbociclib (11,622 reports)

Browse all side effects of Palbociclib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glycosylated haemoglobin increased:

Glycosylated haemoglobin increased (936 drugs)

Browse all the conditions that are associated with Glycosylated haemoglobin increased:

Glycosylated haemoglobin increased (950 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on palbociclib (the active ingredients of Palbociclib) and Palbociclib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.